Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals
Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems....
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Paris
OECD Publishing
2000
|
Schriftenreihe: | OECD Labour Market and Social Policy Occasional Papers
|
Schlagworte: | |
Online-Zugang: | UBA01 UBG01 UEI01 UER01 UPA01 UBR01 UBW01 FFW01 FNU01 EUV01 FRO01 FHR01 FHN01 TUM01 FHI01 UBM01 Volltext |
Zusammenfassung: | Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ... |
Beschreibung: | 1 Online-Ressource (100 Seiten) 21 x 29.7cm |
DOI: | 10.1787/323807375536 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV047935088 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 220413s2000 |||| o||u| ||||||eng d | ||
024 | 7 | |a 10.1787/323807375536 |2 doi | |
035 | |a (ZDB-13-SOC)061271608 | ||
035 | |a (OCoLC)1312692937 | ||
035 | |a (DE-599)BVBBV047935088 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-384 |a DE-91 |a DE-473 |a DE-824 |a DE-29 |a DE-739 |a DE-355 |a DE-20 |a DE-1028 |a DE-1049 |a DE-188 |a DE-521 |a DE-861 |a DE-898 |a DE-92 |a DE-573 |a DE-19 | ||
100 | 1 | |a Jacobzone, Stephane |e Verfasser |4 aut | |
245 | 1 | 0 | |a Pharmaceutical Policies in OECD Countries |b Reconciling Social and Industrial Goals |c Stephane Jacobzone |
264 | 1 | |a Paris |b OECD Publishing |c 2000 | |
300 | |a 1 Online-Ressource (100 Seiten) |c 21 x 29.7cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a OECD Labour Market and Social Policy Occasional Papers | |
520 | |a Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ... | ||
650 | 4 | |a Social Issues/Migration/Health | |
856 | 4 | 0 | |u https://doi.org/10.1787/323807375536 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-13-SOC | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-033316582 | ||
966 | e | |u https://doi.org/10.1787/323807375536 |l UBA01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l UBG01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l UEI01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l UER01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l UPA01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l UBR01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l UBW01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l FFW01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l FNU01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l EUV01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l FRO01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l FHR01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l FHN01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l TUM01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l FHI01 |p ZDB-13-SOC |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1787/323807375536 |l UBM01 |p ZDB-13-SOC |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804183576416092160 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Jacobzone, Stephane |
author_facet | Jacobzone, Stephane |
author_role | aut |
author_sort | Jacobzone, Stephane |
author_variant | s j sj |
building | Verbundindex |
bvnumber | BV047935088 |
collection | ZDB-13-SOC |
ctrlnum | (ZDB-13-SOC)061271608 (OCoLC)1312692937 (DE-599)BVBBV047935088 |
discipline | Wirtschaftswissenschaften |
discipline_str_mv | Wirtschaftswissenschaften |
doi_str_mv | 10.1787/323807375536 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03664nmm a2200517zc 4500</leader><controlfield tag="001">BV047935088</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220413s2000 |||| o||u| ||||||eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/323807375536</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-13-SOC)061271608</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1312692937</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047935088</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-1028</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-861</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jacobzone, Stephane</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical Policies in OECD Countries</subfield><subfield code="b">Reconciling Social and Industrial Goals</subfield><subfield code="c">Stephane Jacobzone</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (100 Seiten)</subfield><subfield code="c">21 x 29.7cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OECD Labour Market and Social Policy Occasional Papers</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ...</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social Issues/Migration/Health</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033316582</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">UBA01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">UEI01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">UER01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">UPA01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">UBW01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">FFW01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">FNU01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">EUV01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">FHR01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">FHI01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="l">UBM01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV047935088 |
illustrated | Not Illustrated |
index_date | 2024-07-03T19:35:03Z |
indexdate | 2024-07-10T09:25:38Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033316582 |
oclc_num | 1312692937 |
open_access_boolean | |
owner | DE-384 DE-91 DE-BY-TUM DE-473 DE-BY-UBG DE-824 DE-29 DE-739 DE-355 DE-BY-UBR DE-20 DE-1028 DE-1049 DE-188 DE-521 DE-861 DE-898 DE-BY-UBR DE-92 DE-573 DE-19 DE-BY-UBM |
owner_facet | DE-384 DE-91 DE-BY-TUM DE-473 DE-BY-UBG DE-824 DE-29 DE-739 DE-355 DE-BY-UBR DE-20 DE-1028 DE-1049 DE-188 DE-521 DE-861 DE-898 DE-BY-UBR DE-92 DE-573 DE-19 DE-BY-UBM |
physical | 1 Online-Ressource (100 Seiten) 21 x 29.7cm |
psigel | ZDB-13-SOC |
publishDate | 2000 |
publishDateSearch | 2000 |
publishDateSort | 2000 |
publisher | OECD Publishing |
record_format | marc |
series2 | OECD Labour Market and Social Policy Occasional Papers |
spelling | Jacobzone, Stephane Verfasser aut Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Stephane Jacobzone Paris OECD Publishing 2000 1 Online-Ressource (100 Seiten) 21 x 29.7cm txt rdacontent c rdamedia cr rdacarrier OECD Labour Market and Social Policy Occasional Papers Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ... Social Issues/Migration/Health https://doi.org/10.1787/323807375536 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Jacobzone, Stephane Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Social Issues/Migration/Health |
title | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals |
title_auth | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals |
title_exact_search | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals |
title_exact_search_txtP | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals |
title_full | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Stephane Jacobzone |
title_fullStr | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Stephane Jacobzone |
title_full_unstemmed | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Stephane Jacobzone |
title_short | Pharmaceutical Policies in OECD Countries |
title_sort | pharmaceutical policies in oecd countries reconciling social and industrial goals |
title_sub | Reconciling Social and Industrial Goals |
topic | Social Issues/Migration/Health |
topic_facet | Social Issues/Migration/Health |
url | https://doi.org/10.1787/323807375536 |
work_keys_str_mv | AT jacobzonestephane pharmaceuticalpoliciesinoecdcountriesreconcilingsocialandindustrialgoals |